Anna Protopapas

Anna Protopapas

Verkställande Direktör på
Flare Therapeutics, Inc.
61 år
Health Technology
Consumer Services
Process Industries

Profil

Anna Protopapas is Chief Executive Officer & Director at Flare Therapeutics, Inc. starting in 2026.
Former roles include Independent Chairman at Nuvalent, Inc. from 2022 to 2026; Director at Mersana Therapeutics, Inc. from 2023 to 2026; Independent Director at Dicerna Pharmaceuticals, Inc. from 2019 to 2021; Director at Bioverativ, Inc. from 2017 to 2018; Independent Director at ARIAD Pharmaceuticals, Inc. from 2015 to 2017; Director at Ensemble Therapeutics Corp.; President & Chief Executive Officer at Millennium Pharmaceuticals, Inc. from 2013 to 2014; Executive VP-Global Business Development at Takeda Pharmaceutical Co., Ltd. from 2010 to 2014; and Head-Global Business Development at Takeda Pharmaceuticals International, Inc. from 2010 to 2014.
Education includes graduate studies at Massachusetts Institute of Technology, undergraduate studies at Princeton University, and an MBA from Stanford Graduate School of Business.

Aktiva positioner av Anna Protopapas

FöretagPositionStart
Verkställande Direktör 2026-06-30

Tidigare kända positioner av Anna Protopapas

FöretagPositionSlut
NUVALENT, INC. Ordförande 2026-07-15
MERSANA THERAPEUTICS Verkställande Direktör 2023-09-10
DICERNA PHARMACEUTICALS, INC. Direktör/Styrelseledamot 2021-06-03
BIOVERATIV INC Direktör/Styrelseledamot 2018-03-08
ARIAD PHARMACEUTICALS, INC. Direktör/Styrelseledamot 2017-01-16
Se detaljerna i Anna Protopapass erfarenhet

Anna Protopapass utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

82

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Anna Protopapas